Veradermics

Today we announced positive topline results from the Phase 3 ‘304’ clinical trial of our investigational oral therapy VDPHL01 in men with pattern hair loss. Key highlights: - Met all primary and secondary endpoints - Showed statistically significant hair growth versus placebo at Month 6, as early as Month 2  - Generally well tolerated, with no treatment-related serious adverse events and no adverse events of special interest of cardiac origin Together with positive topline findings from the Phase 2/3 ‘302’ clinical trial announced in April, we have now reported positive topline efficacy and safety results from both of our registration-directed trials in men with pattern hair loss, which enrolled more than 1,000 men in total. Swipe for a summary and what’s next. Read the full release: https://lnkd.in/gVFJK62s

Our team is growing! We're thrilled to welcome Ravi Panchmatia, MBA, CPA, Rachel Lehman, and Ashley Delgadillo Chavez to Veradermics. Swipe through to meet the newest members of our team!

Should you need a before-and-after photo to know whether you’re getting more hair? Veradermics CEO and board-certified dermatologist Reid Waldman shares why he believes hair growth should speak for itself.

What interests me most about the GLP-1 story is how telehealth and direct-to-patient platforms have changed the way people get prescription medicines. That's especially relevant in categories where people already know they have a problem and are looking for help. Hair loss is one of those categories. The opportunity is to make it easier to go from looking for treatment to getting care. I recently talked with Fraiser Kansteinerr on Fierce Pharma's The Top Line podcast about what that shift could mean for the hair loss market.  https://lnkd.in/gpEx2hWU

Did you know? Measuring a hair count sounds objective, but whether the result is reliable depends on how it's measured.   In a clinical trial, it’s important to have confidence that the same target area can be identified across visits, and that hairs within that area are detected and classified consistently. A hair count is only useful if the method has shown that it can measure the same area in the same way with precision every time. How can you determine whether a hair count is reliable? Swipe to see five questions that can help.

Class was in session last week at Deloitte University. Our Chief Financial Officer, Dominic Carrano, CPA, took the stage at the Deloitte CFO Growth Conference as part of The CFO Journey: Leadership Lessons from the Field panel. Speaking to finance leaders from some of the most ambitious companies in the market, Dom shared his perspective on Veradermics’ evolution and what it takes to help guide a company through significant growth.   Thank you to Deloitte and Deloitte University for bringing the conversation together.

Humans have been trying to treat hair loss for more than 3,500 years. From crocodile fat to early clues about hormones, transplantation techniques and modern drug therapy, the search for solutions has taken some interesting turns. Swipe through for a brief look at how hair loss treatment evolved.

Myth: Wearing hats causes hair loss. It's a common thing people believe about hair loss and one of the easiest myths to debunk. The Reality: Pattern hair loss, also known as androgenetic alopecia, is the most common form of hair loss in both men and women and is caused by a combination of genetics and hormones. A hat plays no role in that process. There is a real condition called traction alopecia, which is a different type of hair loss caused by chronic, tight mechanical pulling on the hair over time, such as very tight braids or extensions worn consistently for years. A hat is not that. Why this Matters: The persistence of this myth has a real cost: it gives people something other than biology to blame, and it delays the kind of conversation with a clinician that could actually help. It may also discourage some from wearing hats, which can actually provide your scalp – and face – with important protection from the sun. If you're noticing changes in your hair, don’t blame the hat. Pattern hair loss is a medical condition with real biological underpinnings, and it deserves a candid conversation with a dermatologist. #HairLoss #AndrogeneticAlopecia #Dermatology #HairLossAwarenessMonth

Pattern hair loss affects ~80 million men and women in the U.S. alone. Yet for nearly 30 years, the FDA-approved prescription drug landscape has barely changed. Over that time, treatment expanded through off-label use, procedures and other approaches supported by varying levels of evidence. The result is a disconnect. There are more ways to approach pattern hair loss, but few prescription therapies developed, rigorously studied and approved specifically for the condition. After nearly 30 years, there’s still significant room for progress in pattern hair loss treatment. #HairLossAwarenessMonth

The 2nd Annual Hair Health Summit is a wrap, and we’re already looking forward to what comes next. Two years in, this meeting is doing something that matters: engaging dedicated clinicians in serious conversation about an impactful condition that has been dismissed as cosmetic for far too long. The discussions on new developments in alopecia and hair loss treatment, the insights from clinicians in the trenches every day, and the sense of a community forming around a shared purpose — it was everything you’d want from a conference in a field that’s finally getting the attention it deserves. The momentum is real. We feel it. #HairHealthSummit  #Alopecia  #HairLoss